Symbol: |
PTGDR2
|
Description: |
prostaglandin D2 receptor 2 [Source:HGNC Symbol;Acc:4502]
|
Location: |
Chr11:60618413-60623444[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:344
Gene |
Compound |
Gen_sig |
Exp_pattern |
PTGDR2 |
NSC 604979 |
0.004 |
Down |
PTGDR2 |
NSC 606398 |
0.007 |
Down |
PTGDR2 |
NSC 607281 |
0.043 |
Down |
PTGDR2 |
Camptothecin hemisuccinate sodium salt |
0.029 |
Down |
PTGDR2 |
Camptothecin lysinate HCl |
0.047 |
Down |
PTGDR2 |
NSC 611229 |
0.047 |
Down |
PTGDR2 |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.001 |
Down |
PTGDR2 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.041 |
Down |
PTGDR2 |
3-Deazaneplanocin, hydrochloride |
0.039 |
Down |
PTGDR2 |
2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- |
0.043 |
Down |
PTGDR2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.049 |
Up |
PTGDR2 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.001 |
Down |
PTGDR2 |
ANTINEOPLASTIC-625543 |
0.045 |
Down |
PTGDR2 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.013 |
Up |
PTGDR2 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.029 |
Down |
Expression pattern: Sensitivity / Resistance
Total:23 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:36
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|